129 related articles for article (PubMed ID: 36681316)
1. Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation.
Peng Y; Tang R; Ding L; Zheng R; Liu Y; Yin L; Fu Y; Deng T; Li X
Eur J Pharmacol; 2023 Mar; 942():175522. PubMed ID: 36681316
[TBL] [Abstract][Full Text] [Related]
2. Structure-based screening combined with computational and biochemical analyses identified the inhibitor targeting the binding of DNA Ligase 1 to UHRF1.
Kori S; Shibahashi Y; Ekimoto T; Nishiyama A; Yoshimi S; Yamaguchi K; Nagatoishi S; Ohta M; Tsumoto K; Nakanishi M; Defossez PA; Ikeguchi M; Arita K
Bioorg Med Chem; 2021 Dec; 52():116500. PubMed ID: 34801826
[TBL] [Abstract][Full Text] [Related]
3. The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1.
Felle M; Joppien S; Németh A; Diermeier S; Thalhammer V; Dobner T; Kremmer E; Kappler R; Längst G
Nucleic Acids Res; 2011 Oct; 39(19):8355-65. PubMed ID: 21745816
[TBL] [Abstract][Full Text] [Related]
4. TIP60 governs the auto‑ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex.
Ahmad T; Ashraf W; Ibrahim A; Zaayter L; Muller CD; Hamiche A; Mély Y; Bronner C; Mousli M
Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34558642
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of
Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
[TBL] [Abstract][Full Text] [Related]
6. M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability.
Ma H; Chen H; Guo X; Wang Z; Sowa ME; Zheng L; Hu S; Zeng P; Guo R; Diao J; Lan F; Harper JW; Shi YG; Xu Y; Shi Y
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4828-33. PubMed ID: 22411829
[TBL] [Abstract][Full Text] [Related]
7. DNA damage regulates UHRF1 stability via the SCF(β-TrCP) E3 ligase.
Chen H; Ma H; Inuzuka H; Diao J; Lan F; Shi YG; Wei W; Shi Y
Mol Cell Biol; 2013 Mar; 33(6):1139-48. PubMed ID: 23297342
[TBL] [Abstract][Full Text] [Related]
8. Discovery and Mechanism of Small Molecule Inhibitors Selective for the Chromatin-Binding Domains of Oncogenic UHRF1.
Liu WH; Miner RE; Albaugh BN; Ananiev GE; Wildman SA; Denu JM
Biochemistry; 2022 Mar; 61(5):354-366. PubMed ID: 35143176
[TBL] [Abstract][Full Text] [Related]
9. The termination of UHRF1-dependent PAF15 ubiquitin signaling is regulated by USP7 and ATAD5.
Miyashita R; Nishiyama A; Qin W; Chiba Y; Kori S; Kato N; Konishi C; Kumamoto S; Kozuka-Hata H; Oyama M; Kawasoe Y; Tsurimoto T; Takahashi TS; Leonhardt H; Arita K; Nakanishi M
Elife; 2023 Feb; 12():. PubMed ID: 36734974
[TBL] [Abstract][Full Text] [Related]
10. Effect of dihydroartemisinin on UHRF1 gene expression in human prostate cancer PC-3 cells.
Du S; Xu G; Zou W; Xiang T; Luo Z
Anticancer Drugs; 2017 Apr; 28(4):384-391. PubMed ID: 28059831
[TBL] [Abstract][Full Text] [Related]
11. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.
Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM
Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138
[TBL] [Abstract][Full Text] [Related]
12. An Allosteric Interaction Links USP7 to Deubiquitination and Chromatin Targeting of UHRF1.
Zhang ZM; Rothbart SB; Allison DF; Cai Q; Harrison JS; Li L; Wang Y; Strahl BD; Wang GG; Song J
Cell Rep; 2015 Sep; 12(9):1400-6. PubMed ID: 26299963
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Ubiquitin-like with Plant Homeodomain and RING Finger Domain 1 (UHRF1) Protein Stability by Heat Shock Protein 90 Chaperone Machinery.
Ding G; Chen P; Zhang H; Huang X; Zang Y; Li J; Li J; Wong J
J Biol Chem; 2016 Sep; 291(38):20125-35. PubMed ID: 27489107
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells.
Ciaco S; Mazzoleni V; Javed A; Eiler S; Ruff M; Mousli M; Mori M; Mély Y
Bioorg Chem; 2023 Aug; 137():106616. PubMed ID: 37247564
[TBL] [Abstract][Full Text] [Related]
15. The finger loop of the SRA domain in the E3 ligase UHRF1 is a regulator of ubiquitin targeting and is required for the maintenance of DNA methylation.
Vaughan RM; Rothbart SB; Dickson BM
J Biol Chem; 2019 Oct; 294(43):15724-15732. PubMed ID: 31481468
[TBL] [Abstract][Full Text] [Related]
16. AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer.
Fu Y; Cao T; Zou X; Ye Y; Liu Y; Peng Y; Deng T; Yin L; Li X
Oncogenesis; 2023 Jan; 12(1):1. PubMed ID: 36593255
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Analysis of Azacitidine-Induced Degradation Profiles Identifies Multiple Chromatin and Epigenetic Regulators Including Uhrf1 and Dnmt1 as Sensitive to Azacitidine.
Bowler EH; Bell J; Divecha N; Skipp P; Ewing RM
J Proteome Res; 2019 Mar; 18(3):1032-1042. PubMed ID: 30672294
[TBL] [Abstract][Full Text] [Related]
18. Screening inhibitors for blocking UHRF1-methylated DNA interaction with capillary electrophoresis.
Lou C; Ye X; Chen G; Zhu J; Kang J
J Chromatogr A; 2021 Jan; 1636():461790. PubMed ID: 33340746
[TBL] [Abstract][Full Text] [Related]
19. PLK1 maintains DNA methylation and cell viability by regulating phosphorylation-dependent UHRF1 protein stability.
Peng Y; Liu Y; Zheng R; Ye Y; Fu Y; Yin L; Gao Y; Fu Y; Qi X; Deng T; Zhang S; Li X
Cell Death Discov; 2023 Oct; 9(1):367. PubMed ID: 37788997
[TBL] [Abstract][Full Text] [Related]
20. Dihydroartemisinin induces cell apoptosis through repression of UHRF1 in prostate cancer cells.
Xia T; Liu S; Xu G; Zhou S; Luo Z
Anticancer Drugs; 2022 Jan; 33(1):e113-e124. PubMed ID: 34387595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
